ACURA PHARMACEUTICALS, INC 4
4 · ACURA PHARMACEUTICALS, INC · Filed Feb 20, 2014
Insider Transaction Report
Form 4
CLAUDIUS LLC
10% Owner
Transactions
- Sale
Common Stock
2014-02-18$1.95/sh−2,200$4,290→ 11,526,398 total(indirect: See FN)
Footnotes (2)
- [F1]The shares were sold as follows: 2,010 by Galen Partners III, L.P. ("Galen III"), 182 by Galen Partners International III, L.P. ("Galen International") and 8 by Galen Employee Fund III, L.P. ("Employee Fund").
- [F2]The shares are held as follows: 10,533,068 by Galen III, 949,942 by Galen International and 43,388 by Employee Fund. Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.